Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice
- PMID: 16100048
- DOI: 10.1161/01.RES.0000181171.65293.65
Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice
Abstract
Protection by ischemic preconditioning is lost in cardiomyocytes and hearts of heterozygous connexin 43 deficient (Cx43+/-) mice. Because connexin 43 (Cx43) is localized in cardiomyocyte mitochondria and mitochondrial Cx43 content is increased with ischemic preconditioning, we now tried to identify a functional defect at the level of the mitochondria in Cx43+/- mice by use of diazoxide and menadione. Diazoxide stimulates the mitochondrial formation of reactive oxygen species (ROS) and menadione generates superoxide at multiple intracellular sites; both substances elicit cardioprotection through increased ROS formation. ROS formation in response to the potassium ionophore valinomycin was also measured for comparison. Menadione (2 micromol/L) and valinomycin (10 nmol/L) induced similar ROS formation in wild-type (WT) and Cx43+/- cardiomyocytes. In contrast, diazoxide (200 micromol/L) increased ROS formation by 43+/-10% versus vehicle in WT, but only by 18+/-4% in Cx43+/- cardiomyoctes (P<0.05). Two hour-simulated ischemia and oxygenated, hypo-osmolar reperfusion reduced viability as compared with normoxia (WT: 7+/-1% versus 39+/-2%, (Cx43+/-): 8+/-1% versus 40+/-3%, P<0.01). Although menadione protected WT and Cx43+/- cardiomyocytes, diazoxide increased viability (17+/-2%, P<0.01) in WT, but not in Cx43+/- (9+/-1%). Menadione (37 microg/kg i.v.) before 30 minutes coronary occlusion and 2 hour reperfusion reduced infarct size in WT and Cx43+/- mice (24+/-4% versus 24+/-5%). In contrast, diazoxide (5 mg/kg i.v.) reduced infarct size in WT (35+/-4% versus 55+/-3% of area at risk, P<0.01), but not in Cx43+/- mice (56+/-2% versus 54+/-3%). Cardiomyocytes of Cx43+/- mice have a specific functional deficit in ROS formation in response to diazoxide and accordingly less protection.
Similar articles
-
Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection.Circ Res. 2006 Jul 7;99(1):93-101. doi: 10.1161/01.RES.0000230315.56904.de. Epub 2006 Jun 1. Circ Res. 2006. PMID: 16741159
-
No loss of cardioprotection by postconditioning in connexin 43-deficient mice.Basic Res Cardiol. 2006 Jul;101(4):354-6. doi: 10.1007/s00395-006-0589-0. Epub 2006 Mar 27. Basic Res Cardiol. 2006. PMID: 16568250
-
Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.Circulation. 2004 Apr 13;109(14):1714-7. doi: 10.1161/01.CIR.0000126294.81407.7D. Epub 2004 Apr 5. Circulation. 2004. PMID: 15066952
-
Connexin 43 in ischemic pre- and postconditioning.Heart Fail Rev. 2007 Dec;12(3-4):261-6. doi: 10.1007/s10741-007-9032-3. Heart Fail Rev. 2007. PMID: 17516165 Review.
-
Connexin 43 and ischemic preconditioning: effects of age and disease.Exp Gerontol. 2006 May;41(5):485-8. doi: 10.1016/j.exger.2006.01.011. Epub 2006 Mar 14. Exp Gerontol. 2006. PMID: 16537100 Review.
Cited by
-
Connexin 43 modulates reverse electron transfer in cardiac mitochondria from inducible knock-out Cx43Cre-ER(T)/fl mice by altering the coenzyme Q pool.Basic Res Cardiol. 2024 May 9. doi: 10.1007/s00395-024-01052-2. Online ahead of print. Basic Res Cardiol. 2024. PMID: 38724619
-
Mitochondrial Kinase Signaling for Cardioprotection.Int J Mol Sci. 2024 Apr 19;25(8):4491. doi: 10.3390/ijms25084491. Int J Mol Sci. 2024. PMID: 38674076 Free PMC article. Review.
-
Pharmaceutical Manipulation of Mitochondrial F0F1-ATP Synthase Enables Imaging and Protection of Myocardial Ischemia/Reperfusion Injury Through Stress-induced Selective Enrichment.Adv Sci (Weinh). 2024 Mar;11(9):e2307880. doi: 10.1002/advs.202307880. Epub 2023 Dec 14. Adv Sci (Weinh). 2024. PMID: 38093654 Free PMC article.
-
Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario.Front Cardiovasc Med. 2023 Apr 19;10:1173462. doi: 10.3389/fcvm.2023.1173462. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37153458 Free PMC article.
-
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.Pharmacol Rev. 2023 Jan;75(1):159-216. doi: 10.1124/pharmrev.121.000348. Epub 2022 Dec 8. Pharmacol Rev. 2023. PMID: 36753049 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources